• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期阿片类药物治疗在门诊姑息医学诊所治疗慢性疼痛的效果。

Effectiveness of Long-Term Opioid Therapy for Chronic Pain in an Outpatient Palliative Medicine Clinic.

机构信息

Supportive and Palliative Care, Orlando Health Cancer Institute, Orlando, Florida, USA.

University of Central Florida College of Medicine, Orlando, Florida, USA.

出版信息

J Palliat Med. 2024 Jan;27(1):31-38. doi: 10.1089/jpm.2023.0251. Epub 2023 Aug 8.

DOI:10.1089/jpm.2023.0251
PMID:37552851
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10790545/
Abstract

Despite widespread use of opioid therapy in outpatient palliative medicine, there is limited evidence supporting its efficacy and safety in the long term. We sought to improve overdose risk scores, maintain pain reduction, and preserve patient function in a cohort with severe chronic pain as we managed opioid therapy for a duration of four years in an outpatient palliative care clinic. Over four years, we provided ongoing goal-concordant outpatient palliative care, including opioid therapy, using quarterly clinical encounters for a patient cohort with chronic pain. The project took place in the outpatient palliative medicine clinic of a regional cancer center in Orlando, Florida (United States). The subjects were a cohort group who received palliative care during the time period between July 2018 and October 2022. Key metrics included treatment-related reduction in pain intensity, performance scores, and overall overdose risk scores. Secondary metrics included cohort demographics, average daily opioid use in morphine milligram equivalents and categorization of type of pain. In 97 patients, we observed a stable mean treatment-related reduction in pain intensity of 4.9 out of 10 points over four years. The cohort showed a 2-point (out of 100) improvement in performance scores and an 81-point (out of 999) reduction in mean overall overdose risk score. We present evidence that providing outpatient palliative care longitudinally over four years offered lasting treatment-related reductions in pain intensity, preservation of performance status, and reduction in overall overdose risk.

摘要

尽管阿片类药物疗法在门诊姑息治疗中广泛应用,但长期疗效和安全性的证据有限。我们旨在提高重度慢性疼痛患者的过量风险评分,维持疼痛缓解,并保持患者的功能,我们在一家门诊姑息治疗诊所管理阿片类药物治疗长达四年。在四年期间,我们通过每季度一次的临床随访,为慢性疼痛患者群体提供持续的、符合目标的门诊姑息治疗,包括阿片类药物治疗。该项目在佛罗里达州奥兰多的一家地区癌症中心的门诊姑息治疗诊所进行。研究对象为 2018 年 7 月至 2022 年 10 月期间接受姑息治疗的患者群体。主要指标包括与治疗相关的疼痛强度、表现评分和总体过量风险评分的降低。次要指标包括患者群体的人口统计学特征、平均每日吗啡当量的阿片类药物使用量以及疼痛类型的分类。在 97 名患者中,我们观察到四年内与治疗相关的疼痛强度平均稳定降低了 4.9 分。该队列的表现评分提高了 2 分(满分 100 分),总体过量风险评分平均降低了 81 分(满分 999 分)。我们提供的证据表明,四年的长期门诊姑息治疗可提供持久的与治疗相关的疼痛强度降低、保持表现状态和降低总体过量风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/10790545/990a675ca61f/jpm.2023.0251_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/10790545/990a675ca61f/jpm.2023.0251_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/10790545/990a675ca61f/jpm.2023.0251_figure1.jpg

相似文献

1
Effectiveness of Long-Term Opioid Therapy for Chronic Pain in an Outpatient Palliative Medicine Clinic.长期阿片类药物治疗在门诊姑息医学诊所治疗慢性疼痛的效果。
J Palliat Med. 2024 Jan;27(1):31-38. doi: 10.1089/jpm.2023.0251. Epub 2023 Aug 8.
2
Naloxone Prescribing and Education in Outpatient Pain Management and Palliative Care.门诊疼痛管理和姑息治疗中的纳洛酮处方和教育。
J Pain Palliat Care Pharmacother. 2021 Jun;35(2):100-105. doi: 10.1080/15360288.2020.1843587. Epub 2021 Apr 12.
3
Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.加拿大不列颠哥伦比亚省长期接受阿片类药物治疗疼痛的患者中,有无阿片类药物使用障碍者停用和逐渐减少处方阿片类药物与过量用药风险的关系:一项回顾性队列研究。
PLoS Med. 2022 Dec 1;19(12):e1004123. doi: 10.1371/journal.pmed.1004123. eCollection 2022 Dec.
4
Patient-Reported Outcomes and Opioid Use in Outpatients With Chronic Pain.慢性疼痛门诊患者的患者报告结局与阿片类药物使用情况
J Pain. 2017 May;18(5):583-596. doi: 10.1016/j.jpain.2016.12.018. Epub 2017 Jan 12.
5
Chronic Pain and Risk Factors for Opioid Misuse in a Palliative Care Clinic.姑息治疗诊所中的慢性疼痛与阿片类药物滥用风险因素
Am J Hosp Palliat Care. 2015 Sep;32(6):654-9. doi: 10.1177/1049909114531445. Epub 2014 Apr 16.
6
Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy-Observational study.纳洛酮联合处方作为慢性阿片类药物治疗患者的通用预防模型——观察性研究。
Subst Abus. 2016 Oct-Dec;37(4):591-596. doi: 10.1080/08897077.2016.1179704. Epub 2016 Apr 19.
7
Comparison of the Centers for Disease Control (CDC) recommendations and the risk index for overdose or serious opioid-induced respiratory depression (RIOSORD) tool for guiding naloxone coprescribing.比较疾病控制与预防中心(CDC)的建议和用于指导纳洛酮共同处方的阿片类药物过量或严重呼吸抑制风险指数(RIOSORD)工具。
J Opioid Manag. 2023 Mar-Apr;19(2):111-116. doi: 10.5055/jom.2023.0765.
8
Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients.门诊癌症患者的患者报告结局和阿片类药物使用情况。
J Pain. 2018 Mar;19(3):278-290. doi: 10.1016/j.jpain.2017.11.001. Epub 2017 Nov 14.
9
Concurrent use of opioids with benzodiazepines or nonbenzodiazepine sedatives among patients with cancer referred to an outpatient palliative care clinic.癌症患者在姑息治疗门诊就诊时同时使用阿片类药物与苯二氮䓬类或非苯二氮䓬类镇静剂。
Cancer. 2019 Dec 15;125(24):4525-4531. doi: 10.1002/cncr.32484. Epub 2019 Aug 28.
10
Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids.长期服用阿片类药物患者中剂量递减与过量用药或心理健康危机的关联。
JAMA. 2021 Aug 3;326(5):411-419. doi: 10.1001/jama.2021.11013.

引用本文的文献

1
Opioid Use Disorders: Prevention, Diagnosis, and Treatment Strategies to Mitigate Addiction Risks.阿片类物质使用障碍:降低成瘾风险的预防、诊断及治疗策略
Curr Drug Saf. 2025;20(4):450-462. doi: 10.2174/0115748863357891250213094516.

本文引用的文献

1
Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.加拿大不列颠哥伦比亚省长期接受阿片类药物治疗疼痛的患者中,有无阿片类药物使用障碍者停用和逐渐减少处方阿片类药物与过量用药风险的关系:一项回顾性队列研究。
PLoS Med. 2022 Dec 1;19(12):e1004123. doi: 10.1371/journal.pmed.1004123. eCollection 2022 Dec.
2
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.美国疾病预防控制中心 2022 年《疼痛阿片类药物处方临床实践指南》。
MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1.
3
Is Chronic Pain a Disease?
慢性疼痛是一种疾病吗?
J Pain. 2022 Oct;23(10):1651-1665. doi: 10.1016/j.jpain.2022.05.001. Epub 2022 May 13.
4
Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study.从长期到间歇性阿片类药物治疗的转变对阿片类药物相关不良结局发展的影响:一项回顾性队列研究。
Drug Alcohol Depend. 2022 Feb 1;231:109236. doi: 10.1016/j.drugalcdep.2021.109236. Epub 2021 Dec 24.
5
COVID-19 outcomes among adult patients treated with long-term opioid therapy for chronic non-cancer pain in the USA: a retrospective cohort study.美国接受长期阿片类药物治疗慢性非癌性疼痛的成年患者的 COVID-19 结局:一项回顾性队列研究。
BMJ Open. 2021 Nov 26;11(11):e056436. doi: 10.1136/bmjopen-2021-056436.
6
Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test.验证和确定一个处方药物监测计划临床阿片类药物风险指标与世界卫生组织酒精、吸烟和物质使用筛查测试的关联性。
Drug Alcohol Depend. 2021 Nov 1;228:109067. doi: 10.1016/j.drugalcdep.2021.109067. Epub 2021 Sep 24.
7
Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids.长期服用阿片类药物患者中剂量递减与过量用药或心理健康危机的关联。
JAMA. 2021 Aug 3;326(5):411-419. doi: 10.1001/jama.2021.11013.
8
US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life.美国终末期癌症预后不良患者阿片类药物获取情况的趋势。
J Clin Oncol. 2021 Sep 10;39(26):2948-2958. doi: 10.1200/JCO.21.00476. Epub 2021 Jul 22.
9
Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017.开具给癌症伴骨转移患者的处方阿片类药物:2011-2017 年。
Oncologist. 2021 Oct;26(10):e1890-e1892. doi: 10.1002/onco.13898. Epub 2021 Jul 21.
10
Survivorship, Version 1.2021.生存状况,版本 1.2021.
J Natl Compr Canc Netw. 2021 Jun 30;19(6):676-685. doi: 10.6004/jnccn.2021.0028.